Walmart Stock Has Dropped Since Earnings. Could It Keep Falling?
Source: investopedia.com
:max_bytes(150000):strip_icc():format(webp)/DavidMarino-Nachison-1196copy-ce7dc2a121e845ecb9ef6b50c229c551.jpeg)
Walmart shares are down 4% in August through Monday’s close and off an additional 1.5% on the day after a disappointing Q3 outlook spooked investors. Visible Alpha still implies a ~$127 target (~20% above ~$106), but Oppenheimer warns the stock could fall toward the “low $90s” and notes it has not traded below $100 since November. Analysts cite slowing same-store sales growth as justification for the retreat, despite positives like operating profit and e-commerce momentum.
Analysis
The market is likely repricing WMT from “must-own defense” to “quality at risk of de-rating.” When a retailer with this kind of multiple loses visibility on comp acceleration, the first move is usually multiple compression rather than immediate EPS cuts; that can extend for 4-8 weeks if sell-side estimate revisions keep drifting lower. The key mechanism is not earnings collapse but a lower terminal growth assumption, which matters more for a stock priced on consistency than on cyclical torque.
Second-order effects: if WMT’s grocery share gains are maturing, the relative beneficiary is less a direct competitor and more any retailer with cleaner discretionary leverage and better traffic optionality, especially COST and possibly TGT if investors start rotating out of the “perfect execution” trade into laggards with more room for mean reversion. Conversely, suppliers exposed to Walmart shelf-space or private-label velocity could see tougher reorders if traffic softens, but that impact should lag by a quarter or two and is harder to monetize immediately. For the consumer complex, this is a warning that trade-down has limits; if the bellwether is cooling, the next incremental upside in discount retail is likely smaller than consensus expects.
Catalyst path: over days, momentum and technical sellers can push the stock through prior support; over 1-3 months, the next earnings/guidance touchpoint matters more than analyst price targets; over 6-18 months, the question is whether WMT can keep growing above inflation without sacrificing margin. The thesis breaks if management re-accelerates same-store sales, raises holiday guidance, or shows that e-commerce mix is scaling without margin drag. Absent that, the stock can stay in a lower trading range even if fundamentals remain decent.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
Key Decisions for Investors
- Tactical short WMT only on a clean break below the psychologically important $100 level, using 1-2 month put spreads to define risk; target the low-$90s if the market continues to de-rate the multiple, and cover on any guidance reset or reclaim of the post-earnings gap.
- Relative value: long COST / short WMT over the next 1-3 months if you want quality retail exposure without paying for a slowing comp profile; this expresses multiple compression risk at WMT while keeping consumer exposure on.
- Do not chase the selloff intraday; wait for a failed bounce or a fresh analyst revision cycle. If WMT stabilizes above $102-$104 for several sessions, the downside move is likely exhausted and the short becomes poor asymmetry.
- Watch TGT as a sympathy beneficiary only if the market is rotating out of WMT’s premium rather than signaling broad consumer weakness; if TGT cannot outperform on the next retail tape, the consumer slowdown is likely sector-wide and WMT weakness is not isolated.
- Falsifier alert: if the next quarterly update shows accelerating U.S. grocery share or an upward revision to same-store sales, cover any WMT short immediately; that would reset the stock back toward a premium multiple and invalidate the de-rating thesis.
More News
- Martha Stewart says Kmart once paid her $65 million a year in royalties—enough to bankroll her entire empire
- How Corgi Is Using AI and Puppies to Upend ETFs
- ‘The gap was not the awareness’: The company phishing trainings you loathe aren’t enough when nearly 1 in 4 security pros say their MFA is optional
- Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
- Why is T-Mobile stock tumbling today?
- OpenAI projected to bring in $20bn less in revenue than expected